Simple Summary – MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma

ByThe Short Paper

Link to the article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302353/

MicroRNA can have suppressive effects on certain biochemical pathways involved in cancer specifically osteosarcoma in regards to this paper. Using bioinformatics techniques, they were able to hone into specific miRNA that can suppress osteosarcoma.

TL;DR Increases in certain molecular mechanisms can help suppress bone cancer (osteosarcoma)

Similar Posts

Deciphering Bacterial Proteins in Infections

ByThe Short Paper

Bacterial pathogens deliver water- and solute-permeable channels to plant cells Many harmful bacteria that infect animals and plants use a special system to release proteins into their host cells. Understanding how these proteins work in host cells is vital for studying diseases in animals and plants. Researchers have been trying to figure out how a…

Projected decline in European bumblebee populations in the twenty-first century

ByThe Short Paper

Bumblebee populations in Europe are expected to decrease in the 21st century Habitat damage and climate change are causing a major decline in wildlife worldwide, and this trend is expected to get worse in the coming decades. This study focuses on bumblebees, crucial pollinators for crops in Europe. They found that bumblebee populations have been…

Simple Summary – Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

ByThe Short Paper

Link to the article: https://www.nejm.org/doi/full/10.1056/NEJMoa1817073 There is a standard of care in the treatment of chronic lymphocytic leukemia (CLL), a blood cancer common in the older population. The standard of care is the usage of fludarabine, cyclophosphamide, and rituximab; however there is a new treatment that may improve outcomes. This study looks at the usage of ibrutinib-rituximab….

Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma

ByThe Short Paper

This study tested a new treatment called mezigdomide, combined with dexamethasone, for people with multiple myeloma (a type of cancer). The treatment showed promise in patients who had already tried other treatments, including those resistant to lenalidomide and pomalidomide. In the first phase of the study, they tested the treatment on 77 patients to determine…

Efficient Cost-Saving Bidding Strategies for Highway and Bridge Projects

ByThe Short Paper

Scaling Auctions as Insurance: A Case Study in Infrastructure Procurement Most U.S. government spending on highways and bridges involves a bidding process where private construction firms submit price bids for each material needed. Researchers studied bridge maintenance projects in Massachusetts and found that firms bid strategically to minimize risk, especially on uncertain items. They estimated…

An mRNA Vaccine against SARS-CoV-2 – Preliminary Report

ByThe Short Paper

Article This was a phase 1 trial where they tested an mRNA vaccine on 45 patients ages 18 to 55 years old. There were 3 different dose groups, n=15. Each dose group received a total of 2 vaccinations 28 days apart. They found dose appropriate anti-SARS-CoV-2 titer increases. There were some minor side effects “fatigue, chills,…